speb/financial-data huggingface dataset:
Financial ratios for CAF.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 10050718823.529411
Buffett classification: The Gruesome
Stock price: 84.19999999999999
Shares outstanding: 8012429
Market cap (USD): 674646521.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCMC.V — annual report dated 2022-03-31
Total revenue: 0
Operating income: -1745260.8
Net income: -1746989.6
Capital expenditures: 0
Operating cash flow: -866247.2
Net tangible assets: -137867.2
Owner earnings: -1746989.6
Buffett classification: The Gruesome
Stock price: 1.864
Shares outstanding: 39703731
Book value: -137867.19999999998
Market cap (USD): 74007754.584
Debt to equity: -0.05766128564299559
Current ratio: 0.5043486764147579
Quick ratio: 0.5043486764147579
Interest coverage ratio: -1374.6540642722118
Free cash flow (dilution-adjusted): -1039973.6
Buyback yield (%): 0
Retained earnings: -4026231.2
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCMC.V — annual report dated 2023-03-31
Total revenue: 0
Operating income: -2514471.111111111
Net income: -2405854.0740740737
Capital expenditures: 0
Operating cash flow: -1989669.6296296294
Net tangible assets: 597322.2222222221
Owner earnings: -2405854.0740740737
Return on net tangible assets (%): -402.77324106971236
Buffett classification: The Gruesome
Stock price: 0.8666666666666666
Shares outstanding: 39703731
Book value: 597322.2222222221
P/B ratio: 57.60693126732268
Market cap (USD): 34409900.199999996
Debt to equity: 0
Current ratio: 2.9041327817290528
Quick ratio: 2.9041327817290528
Interest coverage ratio: -6040.099644128114
Free cash flow (dilution-adjusted): -2309198.518518518
Buyback yield (%): 0
Retained earnings: -5983566.666666666
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -420.9572350676166
Rule of 40 score: 0
Financial ratios for CCMC.V — annual report dated 2024-03-31
Total revenue: 0
Operating income: -836330.3703703703
Net income: -680805.1851851852
Capital expenditures: 0
Operating cash flow: -671616.2962962963
Net tangible assets: 47892.59259259259
Owner earnings: -680805.1851851852
Return on net tangible assets (%): -1421.5250174000464
Buffett classification: The Gruesome
Stock price: 0.16176470588235292
Shares outstanding: 39703731
Book value: 47892.592592592584
P/B ratio: 134.10554785126487
Market cap (USD): 6422662.367647058
Debt to equity: 0
Current ratio: 1.510396602355616
Quick ratio: 1.510396602355616
Free cash flow (dilution-adjusted): -671616.2962962963
Buyback yield (%): 0
Retained earnings: -6366692.592592592
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1746.2624700332537
Rule of 40 score: 0
Financial ratios for CCMC.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1111111111111111
Shares outstanding: 39703731
Market cap (USD): 4411525.666666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCMC.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -75832.86713286713
Net income: -638558.041958042
Capital expenditures: 0
Operating cash flow: -40231.468531468534
Net tangible assets: 116511.88811188811
Owner earnings: -638558.041958042
Return on net tangible assets (%): -548.0625645211629
Buffett classification: The Gruesome
Stock price: 0.06293706293706294
Shares outstanding: 39703731
Book value: 116511.88811188811
P/B ratio: 21.44704937219408
Market cap (USD): 2498836.216783217
Debt to equity: 0
Current ratio: 2.3546241717142973
Quick ratio: 2.3546241717142973
Free cash flow (dilution-adjusted): -40231.468531468534
Buyback yield (%): 0
Retained earnings: -6056046.853146854
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.08594819100665
Rule of 40 score: 0
Financial ratios for CCMC.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -328081.8181818182
Net income: -122487.41258741259
Capital expenditures: 0
Operating cash flow: -73459.44055944057
Net tangible assets: 848845.4545454546
Owner earnings: -122487.41258741259
Return on net tangible assets (%): -14.429883782908748
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 39703731
Book value: 848845.4545454546
P/B ratio: 3.925074469723994
Market cap (USD): 3331781.6223776224
Debt to equity: 0
Current ratio: 19.222404035248378
Quick ratio: 19.222404035248378
Free cash flow (dilution-adjusted): -85188.1118881119
Buyback yield (%): 0
Retained earnings: -6178534.265734266
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -38.65035931157829
Rule of 40 score: 0
Financial ratios for CCMC.V — annual report dated 2025-03-31
Total revenue: 0
Operating income: -309404.8951048951
Net income: -188479.02097902098
Capital expenditures: 0
Operating cash flow: -251212.58741258743
Net tangible assets: 848845.4545454546
Owner earnings: -188479.02097902098
Return on net tangible assets (%): -22.204162132192717
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 39703731
Book value: 848845.4545454546
P/B ratio: 3.925074469723994
Market cap (USD): 3331781.6223776224
Debt to equity: 0
Current ratio: 19.222404035248378
Quick ratio: 19.222404035248378
Free cash flow (dilution-adjusted): -277853.8461538462
Buyback yield (%): 0
Retained earnings: -6178534.265734266
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -36.45008563668134
Rule of 40 score: 0
Financial ratios for CCMC.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -69293.4306569343
Net income: -104813.86861313868
Capital expenditures: 0
Operating cash flow: -191098.54014598537
Net tangible assets: 781207.299270073
Owner earnings: -104813.86861313868
Return on net tangible assets (%): -13.416908509568756
Buffett classification: The Gruesome
Stock price: 0.1094890510948905
Shares outstanding: 39703731
Book value: 781207.299270073
P/B ratio: 5.564622650324129
Market cap (USD): 4347123.832116788
Debt to equity: 0
Current ratio: 74.52160472624854
Quick ratio: 74.52160472624854
Free cash flow (dilution-adjusted): -191098.54014598537
Buyback yield (%): 0
Retained earnings: -6575295.6204379555
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.870043933496161
Rule of 40 score: 0
Financial ratios for CCMC.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -343625.89928057557
Net income: -320248.2014388489
Capital expenditures: 0
Operating cash flow: -298930.21582733816
Net tangible assets: 707092.0863309354
Owner earnings: -320248.2014388489
Return on net tangible assets (%): -45.29087619981726
Buffett classification: The Gruesome
Stock price: 0.10071942446043167
Shares outstanding: 39703731
Book value: 707092.0863309352
P/B ratio: 5.655468378951996
Market cap (USD): 3998936.935251799
Debt to equity: 0
Current ratio: 35.41138575729991
Quick ratio: 35.41138575729991
Free cash flow (dilution-adjusted): -298930.21582733816
Buyback yield (%): 0
Retained earnings: -6800935.971223022
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -48.59705064210701
Rule of 40 score: 0
Financial ratios for CISS — annual report dated 2023-12-31
Total revenue: 31932202.22222222
Gross profit: 13359990
Operating income: 11586623.333333334
Net income: 10324346.666666666
Capital expenditures: 4777777.777777778
Operating cash flow: 6265715.555555555
Depreciation & amortization: 4560800
Net tangible assets: 61715387.777777776
Owner earnings: 10107368.888888888
Return on net tangible assets (%): 16.37738861057324
Capex to operating income (%): 41.235290388984005
Buffett classification: The Good
Stock price: 18550
P/E ratio: 2665.0014464192086
Shares outstanding: 1483256
Book value: 61715387.77777777
P/B ratio: 445.82720437685197
Market cap (USD): 27514398800
Debt to equity: 0
Current ratio: 0.5086781095830948
Quick ratio: 0.4914153833161283
Interest coverage ratio: 7.62372032802298
COGS to revenue (%): 58.16138859755018
SG&A to revenue (%): 4.175617633220273
Free cash flow (dilution-adjusted): 1446117.7777777778
Buyback yield (%): 0
Retained earnings: 9273243.333333334
Inventory turnover: 24.250315914396264
Receivables turnover: 2.7518542878884342
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.774285879972062
FCF margin (%): 4.528712951627862
Revenue growth (%): 813.1532644992923
Rule of 40 score: 817.6819774509202
Financial ratios for CISS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2394
Shares outstanding: 1483256
Market cap (USD): 3550914864
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CISS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1199.1
Shares outstanding: 1483256
Market cap (USD): 1778572269.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CISS — annual report dated 2024-12-31
Total revenue: 44058438.54166667
Gross profit: 14192314.583333334
Operating income: 10481214.583333334
Net income: -2862882.291666667
Capital expenditures: 1690755.2083333335
Operating cash flow: 26016809.375
Depreciation & amortization: 6435053.125
Net tangible assets: 74334640.625
Owner earnings: 1881415.6249999995
Capex to operating income (%): 16.131290843161267
Buffett classification: The Great
Stock price: 1199.1
Shares outstanding: 1483256
Book value: 74334640.625
P/B ratio: 23.926560411752845
Market cap (USD): 1778572269.6
Debt to equity: 0.00040313192361877607
Current ratio: 0.8741890828647179
Quick ratio: 0.8268853559228959
Interest coverage ratio: 4.06739644515949
COGS to revenue (%): 67.7875225425625
SG&A to revenue (%): 7.035390803516381
Free cash flow (dilution-adjusted): 23974121.875
Buyback yield (%): 0
Retained earnings: 267762.5
Inventory turnover: 32.42837058953931
Receivables turnover: 15.022899068778544
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.300949228901354
FCF margin (%): 54.414370251291
Revenue growth (%): 37.97494527641935
Rule of 40 score: 92.38931552771035
Financial ratios for CISS — quarterly report dated 2025-03-31
Total revenue: 9424634.782608695
Gross profit: 2223050
Operating income: 1341513.0434782607
Net income: 8605261.956521738
Capital expenditures: 0
Operating cash flow: 3580968.4782608696
Depreciation & amortization: 1766816.304347826
Net tangible assets: 86091547.82608695
Owner earnings: 10372078.260869564
Return on net tangible assets (%): 12.047731191710179
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 546
P/E ratio: 23.527981486555056
Shares outstanding: 1483256
Book value: 86091547.82608695
P/B ratio: 9.406937108808743
Market cap (USD): 809857776
Debt to equity: 0.00016281959911632995
Current ratio: 1.0120144469398467
Quick ratio: 0.9350463064063138
Interest coverage ratio: 3.7338093149192995
COGS to revenue (%): 76.41234858137739
SG&A to revenue (%): 7.526689997444255
Free cash flow (dilution-adjusted): 3457459.782608696
Buyback yield (%): 0
Retained earnings: 8178688.043478261
Inventory turnover: 4.1341441727572175
Receivables turnover: 2.800328908485025
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4910292961369491
FCF margin (%): 36.6853449747332
Rule of 40 score: 36.6853449747332
Financial ratios for CISS — quarterly report dated 2025-06-30
Total revenue: 12632165.88235294
Gross profit: 2229557.6470588236
Operating income: 1244296.4705882354
Net income: -6268764.705882353
Capital expenditures: 0
Operating cash flow: -407656.4705882353
Depreciation & amortization: 1912317.6470588236
Net tangible assets: 87754842.35294119
Owner earnings: -4356447.05882353
Return on net tangible assets (%): -4.964338083250536
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 459.2
P/E ratio: 291.5095042434195
Shares outstanding: 1483256
Book value: 87754842.35294119
P/B ratio: 7.761522178578353
Market cap (USD): 681111155.1999999
Debt to equity: 0.0007846056050052595
Current ratio: 1.6112125668240926
Quick ratio: 1.4112749514392484
Interest coverage ratio: 26.720529533626397
COGS to revenue (%): 82.35015540625935
SG&A to revenue (%): 6.308004933437431
Free cash flow (dilution-adjusted): -733291.7647058824
Buyback yield (%): 0
Retained earnings: 765129.4117647059
Inventory turnover: 7.741167520111921
Receivables turnover: 1.8896586667145359
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2532804418743402
FCF margin (%): -5.804956739289551
Revenue growth (%): 34.03347900189312
Rule of 40 score: 28.22852226260357
Financial ratios for CISS — quarterly report dated 2025-09-30
Total revenue: 5639997.647058824
Gross profit: -3210751.7647058824
Operating income: -4149160
Net income: 3142937.6470588236
Capital expenditures: 0
Operating cash flow: 2922549.411764706
Depreciation & amortization: 1912320
Net tangible assets: 92906305.88235295
Owner earnings: 5055257.647058824
Return on net tangible assets (%): 5.441242765007023
Buffett classification: The Gruesome
Stock price: 300.16
P/E ratio: 81.25183148850346
Shares outstanding: 1483256
Book value: 92906305.88235295
P/B ratio: 4.792076455216869
Market cap (USD): 445214120.96000004
Debt to equity: 0.0005288186605708774
Current ratio: 1.4788770129907953
Quick ratio: 1.3968627061802013
Interest coverage ratio: -1517.5499139414803
COGS to revenue (%): 156.92824652826303
SG&A to revenue (%): 13.260894143051372
Free cash flow (dilution-adjusted): 2797225.882352941
Buyback yield (%): 0
Retained earnings: 3682576.470588235
Inventory turnover: 12.368596535935353
Receivables turnover: 1.3734353316243215
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.258122807777338
FCF margin (%): 49.596224278775246
Revenue growth (%): -55.35209322308009
Rule of 40 score: -5.755868944304844
Financial ratios for CISS — annual report dated 2025-12-31
Total revenue: 40888955.294117644
Gross profit: 5216076.470588235
Operating income: 1605211.7647058824
Net income: 12321423.529411765
Capital expenditures: 190470.58823529413
Operating cash flow: 4708025.882352942
Depreciation & amortization: 7649275.294117647
Net tangible assets: 111881898.8235294
Owner earnings: 19780228.23529412
Return on net tangible assets (%): 17.67956071830113
Capex to operating income (%): 11.865760793884625
Buffett classification: The Great
Stock price: 32.2
P/E ratio: 3.8762439328534426
Shares outstanding: 1483256
Book value: 111881898.8235294
P/B ratio: 0.42688624077906356
Market cap (USD): 47760843.2
Debt to equity: 0.00026026393755919976
Current ratio: 6.205958565810614
Quick ratio: 5.815214474716746
Interest coverage ratio: 3.6449729117467915
COGS to revenue (%): 87.24331195779261
SG&A to revenue (%): 6.982570181759424
Free cash flow (dilution-adjusted): 4076115.294117647
Buyback yield (%): 0
Retained earnings: 5277464.705882353
Inventory turnover: 23.110147996055066
Receivables turnover: 8.1530690351398
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.434297876746547
FCF margin (%): 9.96874404053078
Revenue growth (%): -7.193816559230994
Rule of 40 score: 2.7749274812997857
Financial ratios for CISS — quarterly report dated 2025-12-31
Total revenue: 12416010.588235294
Gross profit: 3791145.882352941
Operating income: 3058084.7058823532
Net income: 6133320
Capital expenditures: 0
Operating cash flow: -1682738.8235294118
Depreciation & amortization: 1912318.8235294118
Net tangible assets: 111881898.8235294
Owner earnings: 8045638.823529412
Return on net tangible assets (%): 7.191189019968053
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 32.2
P/E ratio: 4.112791807004107
Shares outstanding: 1483256
Book value: 111881898.8235294
P/B ratio: 0.42688624077906356
Market cap (USD): 47760843.2
Debt to equity: 0.00026026393755919976
Current ratio: 6.205958565810614
Quick ratio: 5.815214474716746
Interest coverage ratio: 1381.9096225412015
COGS to revenue (%): 69.46566809515116
SG&A to revenue (%): 4.3698984868588555
Free cash flow (dilution-adjusted): -1730010.5882352942
Buyback yield (%): 0
Retained earnings: 5277464.705882353
Inventory turnover: 5.587491292332222
Receivables turnover: 2.4756952272016597
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.732477108004387
FCF margin (%): -13.933707417055153
Revenue growth (%): 120.14212354698519
Rule of 40 score: 106.20841612993004
Financial ratios for CRD.B — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.52
Shares outstanding: 18946274
Market cap (USD): 123529706.47999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRD.B — annual report dated 2022-12-31
Total revenue: 1231226000
Gross profit: 306354000
Operating income: 50604000
Net income: -18305000
Capital expenditures: 3806000
Operating cash flow: 27634000
Depreciation & amortization: 36098000
Net tangible assets: -123094000
Owner earnings: 13987000
Capex to operating income (%): 7.521144573551498
Buffett classification: The Great
Stock price: 4.79
Shares outstanding: 18946274
Book value: 123378000
P/B ratio: 0.7355659230981212
Market cap (USD): 90752652.46
Debt to equity: 2.807599409943426
Current ratio: 1.2568276878709923
Quick ratio: 1.2568276878709923
Effective tax rate (%): 467.26119698771305
Interest coverage ratio: 4.614627028998723
COGS to revenue (%): 75.11797184269989
SG&A to revenue (%): 20.771978499479378
Free cash flow (dilution-adjusted): -11888000
Buyback yield (%): 29.474620603281927
Retained earnings: 213094000
Receivables turnover: 4.453251253264274
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.883207687199718
FCF margin (%): -0.9655416633501892
Rule of 40 score: -0.9655416633501892
Financial ratios for CRD.B — annual report dated 2023-12-31
Total revenue: 1316919000
Gross profit: 359072000
Operating income: 72566000
Net income: 30609000
Capital expenditures: 4890000
Operating cash flow: 103790000
Depreciation & amortization: 35742000
Net tangible assets: -113662000
Owner earnings: 61461000
Return on net tangible assets (%): -54.07348102268128
Capex to operating income (%): 6.738693051842461
Buffett classification: The Great
Stock price: 12.2
P/E ratio: 7.551522192819105
Shares outstanding: 18946274
Book value: 139831000
P/B ratio: 1.6530278893807524
Market cap (USD): 231144542.79999998
Debt to equity: 2.22788938075248
Current ratio: 1.2340657284524812
Quick ratio: 1.2340657284524812
Effective tax rate (%): 36.1023713495365
Interest coverage ratio: 3.663284365692362
COGS to revenue (%): 72.73393428145542
SG&A to revenue (%): 21.75577996824406
Free cash flow (dilution-adjusted): 61591000
Buyback yield (%): 1.1815117791307856
Retained earnings: 228564000
Receivables turnover: 5.209022407689417
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.515899957392076
FCF margin (%): 4.676901160967379
Revenue growth (%): 6.9599732299350405
Rule of 40 score: 11.63687439090242
Financial ratios for CRD.B — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.59
Shares outstanding: 18946274
Market cap (USD): 200641041.66
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRD.B — annual report dated 2024-12-31
Total revenue: 1340970000
Gross profit: 367547000
Operating income: 67883000
Net income: 26596000
Capital expenditures: 6210000
Operating cash flow: 51619000
Depreciation & amortization: 36195000
Net tangible assets: -105557000
Owner earnings: 56581000
Return on net tangible assets (%): -53.60231912615932
Capex to operating income (%): 9.14809304244067
Buffett classification: The Great
Stock price: 11.15
P/E ratio: 7.94295965934727
Shares outstanding: 18946274
Book value: 155551000
P/B ratio: 1.3580816266047793
Market cap (USD): 211250955.1
Debt to equity: 1.989630410604882
Current ratio: 1.2485595224988073
Quick ratio: 1.2485595224988073
Effective tax rate (%): 35.47139521307648
Interest coverage ratio: 3.343496035068709
COGS to revenue (%): 72.5909602750248
SG&A to revenue (%): 22.346808653437435
Free cash flow (dilution-adjusted): 4204000
Buyback yield (%): 1.8305242682427048
Retained earnings: 237948000
Receivables turnover: 4.815301582513708
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.468100978517066
FCF margin (%): 0.31350440352878883
Revenue growth (%): 1.8263082239682167
Rule of 40 score: 2.1398126274970055
Financial ratios for CRD.B — quarterly report dated 2024-12-31
Total revenue: 358318000
Gross profit: 94902000
Operating income: 23815000
Net income: 5861000
Capital expenditures: 3218000
Operating cash flow: 40526000
Depreciation & amortization: 9238000
Net tangible assets: -105557000
Owner earnings: 11881000
Return on net tangible assets (%): -11.255530187481645
Capex to operating income (%): 13.512492126810832
Buffett classification: The Great
Stock price: 11.15
P/E ratio: 9.010875068247739
Shares outstanding: 18946274
Book value: 155551000
P/B ratio: 1.3580816266047793
Market cap (USD): 211250955.1
Debt to equity: 1.989630410604882
Current ratio: 1.2485595224988073
Quick ratio: 1.2485595224988073
Effective tax rate (%): 38.8076842764669
Interest coverage ratio: 4.561386707527293
COGS to revenue (%): 73.51458760095781
SG&A to revenue (%): 19.83908148627755
Free cash flow (dilution-adjusted): 26375000
Buyback yield (%): 0.12449647854870219
Retained earnings: 237948000
Receivables turnover: 1.2866874221221556
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.72493591625862
FCF margin (%): 7.360780089194514
Rule of 40 score: 7.360780089194514
Financial ratios for CRD.B — quarterly report dated 2025-03-31
Total revenue: 323339000
Gross profit: 90139000
Operating income: 15552000
Net income: 6740000
Capital expenditures: 994000
Operating cash flow: -13923000
Depreciation & amortization: 9647000
Net tangible assets: -101339000
Owner earnings: 15393000
Return on net tangible assets (%): -15.189611107273606
Capex to operating income (%): 6.391460905349794
Buffett classification: The Great
Stock price: 11.01
P/E ratio: 7.737332223293769
Shares outstanding: 18946274
Book value: 159023000
P/B ratio: 1.3117503552316332
Market cap (USD): 208598476.74
Debt to equity: 2.084031869603768
Current ratio: 1.3027103329478233
Quick ratio: 1.3027103329478233
Effective tax rate (%): 26.89804772234273
Interest coverage ratio: 3.259693984489625
COGS to revenue (%): 72.1224473385518
SG&A to revenue (%): 23.06774004991665
Free cash flow (dilution-adjusted): -24636000
Buyback yield (%): 0
Retained earnings: 241177000
Receivables turnover: 1.1734781646155354
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0731655264811546
FCF margin (%): -7.619247910088174
Revenue growth (%): -9.761999118101798
Rule of 40 score: -17.38124702818997
Financial ratios for CRD.B — quarterly report dated 2025-06-30
Total revenue: 334595000
Gross profit: 98273000
Operating income: 17523000
Net income: 7820000
Capital expenditures: 1407000
Operating cash flow: 35006000
Depreciation & amortization: 9814000
Net tangible assets: -87806000
Owner earnings: 16227000
Return on net tangible assets (%): -18.480513860100675
Capex to operating income (%): 8.02944701249786
Buffett classification: The Great
Stock price: 10.15
P/E ratio: 9.417006077077518
Shares outstanding: 18946274
Book value: 175341000
P/B ratio: 1.0967468025162397
Market cap (USD): 192304681.1
Debt to equity: 1.7650806143457605
Current ratio: 1.3381701113443136
Quick ratio: 1.3381701113443136
Effective tax rate (%): 42.77350896450787
Interest coverage ratio: 3.765148259561667
COGS to revenue (%): 70.6292682197881
SG&A to revenue (%): 24.133654119158983
Free cash flow (dilution-adjusted): 24146000
Buyback yield (%): 0
Retained earnings: 245497000
Receivables turnover: 1.169050106390041
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3811540650837903
FCF margin (%): 7.216485601996443
Revenue growth (%): 3.481176103099224
Rule of 40 score: 10.697661705095667
Financial ratios for CRD.B — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.57
P/E ratio: 8.87889144410166
Shares outstanding: 18946274
Market cap (USD): 181315842.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRD.B — quarterly report dated 2025-12-31
Total revenue: 320086000
Gross profit: 84884000
Operating income: 20245000
Net income: -7240000
Capital expenditures: 3249000
Operating cash flow: 50132000
Depreciation & amortization: 10498000
Net tangible assets: -82640000
Owner earnings: 9000
Capex to operating income (%): 16.04840701407755
Buffett classification: The Great
Stock price: 10.57
P/E ratio: 27.358212592896177
Shares outstanding: 18946274
Book value: 171432000
P/B ratio: 1.1681723142703813
Market cap (USD): 200262116.18
Debt to equity: 1.5765668019972934
Current ratio: 1.1383919630455148
Quick ratio: 1.1383919630455148
Interest coverage ratio: 5.113665066936095
COGS to revenue (%): 73.48087701430241
SG&A to revenue (%): 20.194260292546378
Free cash flow (dilution-adjusted): 38812000
Buyback yield (%): 3.7755518338795575
Retained earnings: 233708000
Receivables turnover: 1.2960469042924068
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.452092450465111
FCF margin (%): 12.125491274220053
Rule of 40 score: 12.125491274220053
Financial ratios for CRD.B — annual report dated 2025-12-31
Total revenue: 1310827000
Gross profit: 367088000
Operating income: 72922000
Net income: 19676000
Capital expenditures: 7014000
Operating cash flow: 101847000
Depreciation & amortization: 40043000
Net tangible assets: -82640000
Owner earnings: 52705000
Return on net tangible assets (%): -63.776621490803485
Capex to operating income (%): 9.61849647568635
Buffett classification: The Great
Stock price: 10.57
P/E ratio: 10.17798923460053
Shares outstanding: 18946274
Book value: 171432000
P/B ratio: 1.1681723142703813
Market cap (USD): 200262116.18
Debt to equity: 1.5765668019972934
Current ratio: 1.1383919630455148
Quick ratio: 1.1383919630455148
Effective tax rate (%): 43.13294797687861
Interest coverage ratio: 4.057308184498971
COGS to revenue (%): 71.99569432121858
SG&A to revenue (%): 22.44125273586827
Free cash flow (dilution-adjusted): 58105000
Buyback yield (%): 5.250119293930653
Retained earnings: 233708000
Receivables turnover: 5.30761506411684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.036329250324368
FCF margin (%): 4.432697831216476
Revenue growth (%): -2.2478504366242347
Rule of 40 score: 2.1848473945922415
Financial ratios for CRE.V — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.0476190476190477
Shares outstanding: 232039672
Market cap (USD): 243089180.1904762
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRE.V — annual report dated 2022-08-31
Total revenue: 0
Gross profit: -17767.93893129771
Operating income: -2775424.427480916
Net income: -4903209.923664122
Capital expenditures: 2461252.671755725
Operating cash flow: -4588362.595419847
Depreciation & amortization: 17767.93893129771
Net tangible assets: 45970341.22137404
Owner earnings: -7346694.656488549
Return on net tangible assets (%): -15.98137943138147
Buffett classification: The Gruesome
Stock price: 1.114503816793893
Shares outstanding: 232039672
Book value: 45970341.22137405
P/B ratio: 5.6255640750250056
Market cap (USD): 258609100.091603
Debt to equity: 0.0006844439545463987
Current ratio: 11.361863975047081
Quick ratio: 11.361863975047081
Free cash flow (dilution-adjusted): -7596248.854961831
Buyback yield (%): 0
Retained earnings: -35213662.59541985
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.796177233090846
Rule of 40 score: 0
Financial ratios for CRE.V — annual report dated 2023-08-31
Total revenue: 0
Gross profit: -45177.777777777774
Operating income: -4622124.444444444
Net income: -2409451.8518518517
Capital expenditures: 5526778.518518518
Operating cash flow: -3844054.8148148144
Depreciation & amortization: 45177.777777777774
Net tangible assets: 53380847.4074074
Owner earnings: -7891052.592592591
Return on net tangible assets (%): -14.782553998004888
Buffett classification: The Gruesome
Stock price: 1.1037037037037036
Shares outstanding: 232039672
Book value: 53380847.4074074
P/B ratio: 4.797657920976623
Market cap (USD): 256103045.39259258
Debt to equity: 0.0032924279236564583
Current ratio: 8.16402889526333
Quick ratio: 8.16402889526333
Free cash flow (dilution-adjusted): -10562968.148148147
Buyback yield (%): 0
Retained earnings: -36579746.666666664
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.332848019244798
Rule of 40 score: 0
Financial ratios for CRE.V — annual report dated 2024-08-31
Total revenue: 0
Gross profit: -52026.666666666664
Operating income: -4389957.037037036
Net income: -91897.77777777777
Capital expenditures: 6690507.407407407
Operating cash flow: -4485551.111111111
Depreciation & amortization: 52026.666666666664
Net tangible assets: 54487708.88888889
Owner earnings: -6730378.518518518
Return on net tangible assets (%): -12.352104090563026
Buffett classification: The Gruesome
Stock price: 0.30370370370370364
Shares outstanding: 232039672
Book value: 54487708.88888889
P/B ratio: 1.2933432003224319
Market cap (USD): 70471307.79259259
Debt to equity: 0.0026084170093569315
Current ratio: 9.99678307045732
Quick ratio: 9.99678307045732
Interest coverage ratio: -160.62994985770428
Free cash flow (dilution-adjusted): -12355558.518518519
Buyback yield (%): 0
Retained earnings: -36671644.44444444
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.696651433602207
Rule of 40 score: 0
Financial ratios for CRE.V — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.29285714285714287
Shares outstanding: 232039672
Market cap (USD): 67954475.37142858
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRE.V — quarterly report dated 2025-02-28
Total revenue: 0
Gross profit: -10822.916666666668
Operating income: -792960.4166666667
Net income: 5406390.277777778
Capital expenditures: 136347.22222222222
Operating cash flow: -735009.7222222222
Depreciation & amortization: 10822.916666666668
Net tangible assets: 57689322.222222224
Owner earnings: 5280865.972222223
Return on net tangible assets (%): 9.153974719758462
Buffett classification: The Gruesome
Stock price: 0.4513888888888889
P/E ratio: 4.84334853482286
Shares outstanding: 232039672
Book value: 57689322.222222224
P/B ratio: 1.815589535248098
Market cap (USD): 104740129.72222222
Debt to equity: 0.002016970115209073
Current ratio: 15.418164178600042
Quick ratio: 15.418164178600042
Effective tax rate (%): -0.0002568982973037753
Free cash flow (dilution-adjusted): -1146318.0555555555
Buyback yield (%): 0
Retained earnings: -28273717.361111112
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.309571447063931
Rule of 40 score: 0
Financial ratios for CRE.V — quarterly report dated 2025-05-31
Total revenue: 0
Gross profit: -11670.289855072464
Operating income: -815834.7826086957
Net income: -4242924.63768116
Capital expenditures: 935886.2318840581
Operating cash flow: -403297.82608695654
Depreciation & amortization: 11670.289855072464
Net tangible assets: 56222478.98550725
Owner earnings: -5167140.579710146
Return on net tangible assets (%): -9.190524275961055
Buffett classification: The Gruesome
Stock price: 0.30434782608695654
Shares outstanding: 232039672
Book value: 56222478.98550725
P/B ratio: 1.2560949110289978
Market cap (USD): 70620769.73913044
Debt to equity: 0.0007754131970088142
Current ratio: 13.576578676964084
Quick ratio: 13.576578676964084
Free cash flow (dilution-adjusted): -1627952.8985507248
Buyback yield (%): 0
Retained earnings: -33745934.057971016
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3656277781624249
Rule of 40 score: 0
Financial ratios for CRE.V — annual report dated 2025-08-31
Total revenue: 0
Gross profit: -44754.744525547445
Operating income: -4131495.620437956
Net income: 2967106.5693430654
Capital expenditures: 2440416.7883211677
Operating cash flow: -2821127.737226277
Depreciation & amortization: 44754.744525547445
Net tangible assets: 57731245.25547445
Owner earnings: 571444.5255474453
Return on net tangible assets (%): 0.9898357865288853
Buffett classification: The Gruesome
Stock price: 0.3357664233576642
P/E ratio: 26.258285276816167
Shares outstanding: 232039672
Book value: 57731245.25547445
P/B ratio: 1.3495487651400957
Market cap (USD): 77911130.74452554
Debt to equity: 0.0006947116620399337
Current ratio: 8.377771738962608
Quick ratio: 8.377771738962608
Effective tax rate (%): 0
Interest coverage ratio: -138.91299759485594
Free cash flow (dilution-adjusted): -6354486.861313868
Buyback yield (%): 0
Retained earnings: -33169185.40145985
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.742983636674828
Rule of 40 score: 0
Financial ratios for CRE.V — quarterly report dated 2025-08-31
Total revenue: 0
Gross profit: -9967.153284671533
Operating income: -1568215.3284671532
Net income: 823069.3430656934
Capital expenditures: 83548.90510948905
Operating cash flow: -1149372.9927007298
Depreciation & amortization: 9967.153284671533
Net tangible assets: 57731245.25547445
Owner earnings: 749487.5912408759
Return on net tangible assets (%): 1.2982356225371816
Buffett classification: The Gruesome
Stock price: 0.3357664233576642
P/E ratio: 39.21961173847586
Shares outstanding: 232039672
Book value: 57731245.25547445
P/B ratio: 1.3495487651400957
Market cap (USD): 77911130.74452554
Debt to equity: 0.0006947116620399337
Current ratio: 8.377771738962608
Quick ratio: 8.377771738962608
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -1508235.7664233577
Buyback yield (%): 0
Retained earnings: -33169185.40145985
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.559472711607454
Rule of 40 score: 0
Financial ratios for CRE.V — quarterly report dated 2025-11-30
Total revenue: 0
Gross profit: -11048.57142857143
Operating income: -700690.7142857143
Net income: -3767132.142857143
Capital expenditures: 170856.42857142858
Operating cash flow: -1890450.7142857143
Depreciation & amortization: 11048.57142857143
Net tangible assets: 52750112.85714286
Owner earnings: -3926940.0000000005
Return on net tangible assets (%): -7.4444200918297305
Buffett classification: The Gruesome
Stock price: 0.2785714285714286
Shares outstanding: 232039672
Book value: 52750112.85714286
P/B ratio: 1.2253930733634992
Market cap (USD): 64639622.91428572
Debt to equity: 0.0006717250354427136
Current ratio: 11.335073028215588
Quick ratio: 11.335073028215588
Interest coverage ratio: -29.15726429675425
Free cash flow (dilution-adjusted): -2186454.285714286
Buyback yield (%): 0
Retained earnings: -36264913.571428575
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.246332296098418
Rule of 40 score: 0
Financial ratios for CRE.V — quarterly report dated 2026-02-28
Total revenue: 0
Gross profit: -4775.9124087591235
Operating income: -568216.0583941606
Net income: 2477563.503649635
Capital expenditures: 572615.3284671532
Operating cash flow: -609037.2262773722
Depreciation & amortization: 4775.9124087591235
Net tangible assets: 60069349.63503649
Owner earnings: 1909724.0875912409
Return on net tangible assets (%): 3.1791988746243414
Buffett classification: The Gruesome
Stock price: 0.3503649635036496
P/E ratio: 8.203480061350598
Shares outstanding: 232039672
Book value: 60069349.63503649
P/B ratio: 1.3534118765331198
Market cap (USD): 81298571.21167882
Debt to equity: 0.0005364237823948716
Current ratio: 8.299357111557
Quick ratio: 8.299357111557
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -1202997.0802919706
Buyback yield (%): 0
Retained earnings: -35067379.56204379
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8932139384361241
Rule of 40 score: 0
Financial ratios for CSBR — annual report dated 2022-04-30
Total revenue: 49109000
Gross profit: 25477000
Operating income: 607000
Net income: 548000
Capital expenditures: 2384000
Operating cash flow: 6497000
Depreciation & amortization: 1627000
Net tangible assets: 8761000
Owner earnings: -209000
Return on net tangible assets (%): -2.3855724232393563
Capex to operating income (%): 392.75123558484347
Buffett classification: The Gruesome
Stock price: 7.68
P/E ratio: 194.6182913868613
Shares outstanding: 13886826
Book value: 9096000
P/B ratio: 11.725024591029024
Market cap (USD): 106650823.67999999
Debt to equity: 1.0406772207563764
Current ratio: 1.1250071514388695
Quick ratio: 1.1250071514388695
Effective tax rate (%): 6.003430531732419
COGS to revenue (%): 48.12152558594148
R&D to revenue (%): 19.08815084811338
SG&A to revenue (%): 31.55429758292777
Free cash flow (dilution-adjusted): 3201000
Buyback yield (%): 0
Retained earnings: -71982000
Receivables turnover: 5.1623042152843475
Capitalized R&D asset: 9374000
ROCI (R&D-adjusted, %): 25.139637492513966
FCF margin (%): 6.518153495285997
Rule of 40 score: 6.518153495285997
Financial ratios for CSBR — annual report dated 2023-04-30
Total revenue: 53870000
Gross profit: 24338000
Operating income: -4449000
Net income: -5335000
Capital expenditures: 2872000
Operating cash flow: 3972000
Depreciation & amortization: 2246000
Net tangible assets: 4301000
Owner earnings: -5961000
Return on net tangible assets (%): -138.59567542431992
Buffett classification: The Gruesome
Stock price: 4.92
Shares outstanding: 13886826
Book value: 4636000
P/B ratio: 14.737528886971527
Market cap (USD): 68323183.92
Debt to equity: 1.8548317515099224
Current ratio: 0.8952744673998068
Quick ratio: 0.8952744673998068
COGS to revenue (%): 54.82086504547986
R&D to revenue (%): 21.431223315388902
SG&A to revenue (%): 32.00668275478002
Free cash flow (dilution-adjusted): 236000
Buyback yield (%): 0.10830876981179187
Retained earnings: -77317000
Receivables turnover: 6.724503807265011
Capitalized R&D asset: 17825580
ROCI (R&D-adjusted, %): 0.4045576211748748
Rosenberg metric: -0.12150629400469383
FCF margin (%): 0.43809170224614813
Revenue growth (%): 9.694760634506913
Rule of 40 score: 10.13285233675306
Financial ratios for CSBR — annual report dated 2024-04-30
Total revenue: 50155000
Gross profit: 20754000
Operating income: -6921000
Net income: -7276000
Capital expenditures: 836000
Operating cash flow: -6137000
Depreciation & amortization: 1867000
Net tangible assets: -2238000
Owner earnings: -6245000
Buffett classification: The Gruesome
Stock price: 4.85
Shares outstanding: 13886826
Book value: -1903000
Market cap (USD): 67351106.1
Debt to equity: -3.904361534419338
Current ratio: 0.6331646627361776
Quick ratio: 0.6331646627361776
COGS to revenue (%): 58.62027714086332
R&D to revenue (%): 19.02901006878676
SG&A to revenue (%): 36.14993520087728
Free cash flow (dilution-adjusted): -8091000
Buyback yield (%): 0.9413356909961722
Retained earnings: -84593000
Receivables turnover: 5.265064035271887
Capitalized R&D asset: 20372570
ROCI (R&D-adjusted, %): -30.169296031510452
Rosenberg metric: -0.3104374187960156
FCF margin (%): -16.13199082843186
Revenue growth (%): -6.896231668832374
Rule of 40 score: -23.028222497264235
Financial ratios for CSBR — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.91
Shares outstanding: 13886826
Market cap (USD): 54297489.660000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSBR — quarterly report dated 2025-01-31
Total revenue: 17039000
Gross profit: 10422000
Operating income: 4499000
Net income: 4495000
Capital expenditures: 42000
Operating cash flow: 490000
Depreciation & amortization: 398000
Net tangible assets: 5134000
Owner earnings: 4851000
Return on net tangible assets (%): 94.48772886638099
Capex to operating income (%): 0.9335407868415203
Buffett classification: The Great
Stock price: 10.99
P/E ratio: 8.48810999666296
Shares outstanding: 13886826
Book value: 5469000
P/B ratio: 27.90568984092156
Market cap (USD): 152616217.74
Debt to equity: 1.1769976229658072
Current ratio: 0.991293407146452
Quick ratio: 0.991293407146452
Effective tax rate (%): 0.5090748118636566
COGS to revenue (%): 38.8344386407653
R&D to revenue (%): 10.08862022419156
SG&A to revenue (%): 24.672809437173544
Free cash flow (dilution-adjusted): 192000
Buyback yield (%): 0
Retained earnings: -78057000
Receivables turnover: 1.0796476999112914
Capitalized R&D asset: 1719000
ROCI (R&D-adjusted, %): 45.24687399807631
FCF margin (%): 1.1268266917072598
Rule of 40 score: 1.1268266917072598
Financial ratios for CSBR — quarterly report dated 2025-04-30
Total revenue: 15207000
Gross profit: 5084000
Operating income: -1714000
Net income: -1835000
Capital expenditures: 253000
Operating cash flow: 6868000
Depreciation & amortization: 394000
Net tangible assets: 3437000
Owner earnings: -1694000
Return on net tangible assets (%): -49.287169042769854
Buffett classification: The Gruesome
Stock price: 7.15
Shares outstanding: 13886826
Book value: 3772000
P/B ratio: 26.323119273594912
Market cap (USD): 99290805.9
Debt to equity: 1.6185047720042418
Current ratio: 0.9377856034880309
Quick ratio: 0.9377856034880309
COGS to revenue (%): 47.81350693759453
R&D to revenue (%): 12.908528966923127
SG&A to revenue (%): 31.794568290918658
Free cash flow (dilution-adjusted): 6484000
Buyback yield (%): 0
Retained earnings: -79892000
Receivables turnover: 1.353658536585366
Capitalized R&D asset: 3114730
ROCI (R&D-adjusted, %): -8.429744043100548
Rosenberg metric: -3.1052937754508436
FCF margin (%): 42.63825869665286
Revenue growth (%): -10.751804683373438
Rule of 40 score: 31.886454013279426
Financial ratios for CSBR — annual report dated 2025-04-30
Total revenue: 56944000
Gross profit: 28555000
Operating income: 4846000
Net income: 4701000
Capital expenditures: 389000
Operating cash flow: 7386000
Depreciation & amortization: 1640000
Net tangible assets: 3437000
Owner earnings: 5952000
Return on net tangible assets (%): 173.17427989525748
Capex to operating income (%): 8.027238959966983
Buffett classification: The Great
Stock price: 7.15
P/E ratio: 21.12120950861519
Shares outstanding: 13886826
Book value: 3772000
P/B ratio: 26.323119273594912
Market cap (USD): 99290805.9
Debt to equity: 1.6185047720042418
Current ratio: 0.9377856034880309
Quick ratio: 0.9377856034880309
Effective tax rate (%): -1.621271076523995
COGS to revenue (%): 49.85424276482158
R&D to revenue (%): 11.985459398707501
SG&A to revenue (%): 29.65018263557179
Free cash flow (dilution-adjusted): 6343000
Buyback yield (%): 0
Retained earnings: -79892000
Receivables turnover: 5.068897988249955
Capitalized R&D asset: 17029330
ROCI (R&D-adjusted, %): 9.272346138679765
Rosenberg metric: 0.8173721709974854
FCF margin (%): 11.139013767912335
Revenue growth (%): 13.536038281327883
Rule of 40 score: 24.675052049240218
Financial ratios for CSBR — quarterly report dated 2025-07-31
Total revenue: 13995000
Gross profit: 6000000
Operating income: -507000
Net income: -466000
Capital expenditures: 46000
Operating cash flow: 600000
Depreciation & amortization: 358000
Net tangible assets: 3173000
Owner earnings: -154000
Return on net tangible assets (%): -4.853450992751339
Buffett classification: The Gruesome
Stock price: 6.32
P/E ratio: 40.0021605834093
Shares outstanding: 13886826
Book value: 3538000
P/B ratio: 24.806314392312043
Market cap (USD): 87764740.32000001
Debt to equity: 1.6252119841718484
Current ratio: 0.9258084412723588
Quick ratio: 0.9258084412723588
COGS to revenue (%): 57.12754555198285
R&D to revenue (%): 14.87674169346195
SG&A to revenue (%): 31.618435155412648
Free cash flow (dilution-adjusted): 346000
Buyback yield (%): 0
Retained earnings: -80358000
Receivables turnover: 1.4772007599746675
Capitalized R&D asset: 3964480
ROCI (R&D-adjusted, %): -2.931927362698885
Rosenberg metric: 0.46663270504330107
FCF margin (%): 2.4723115398356557
Revenue growth (%): -7.970013809429869
Rule of 40 score: -5.497702269594213
Financial ratios for CSBR — quarterly report dated 2025-10-31
Total revenue: 15035000
Gross profit: 7773000
Operating income: 185000
Net income: 299000
Capital expenditures: 242000
Operating cash flow: -1735000
Depreciation & amortization: 357000
Net tangible assets: 3835000
Owner earnings: 414000
Return on net tangible assets (%): 10.795306388526727
Capex to operating income (%): 130.8108108108108
Buffett classification: The Gruesome
Stock price: 6.84
P/E ratio: 38.10103884476534
Shares outstanding: 13886826
Book value: 4231000
P/B ratio: 22.449985781139212
Market cap (USD): 94985889.84
Debt to equity: 1.2453320727960293
Current ratio: 0.9634614516056186
Quick ratio: 0.9634614516056186
Effective tax rate (%): 7.0588235294117645
COGS to revenue (%): 48.30063185899567
R&D to revenue (%): 17.399401396740938
SG&A to revenue (%): 33.06950448952444
Free cash flow (dilution-adjusted): -2226000
Buyback yield (%): 0
Retained earnings: -80121000
Receivables turnover: 1.3029725279486957
Capitalized R&D asset: 4658730
ROCI (R&D-adjusted, %): 4.579487628416903
Rosenberg metric: 0.8515850144092219
FCF margin (%): -14.805453940804789
Revenue growth (%): 7.431225437656305
Rule of 40 score: -7.374228503148483
Financial ratios for CWR.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.13472972972972974
Shares outstanding: 213797576
Market cap (USD): 28804889.631351355
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWR.L — annual report dated 2022-12-31
Total revenue: 23840963.85542169
Gross profit: 12902409.638554217
Operating income: -65075903.61445783
Net income: -57367469.87951808
Capital expenditures: 14875903.614457833
Operating cash flow: -61243373.49397591
Depreciation & amortization: 8727710.843373494
Net tangible assets: 265649397.59036145
Owner earnings: -63515662.650602415
Return on net tangible assets (%): -23.909582790978238
Buffett classification: The Gruesome
Stock price: 0.04228915662650602
Shares outstanding: 213797576
Book value: 281646987.95180726
P/B ratio: 0.032101600814486216
Market cap (USD): 9041319.177831326
Debt to equity: 0.013363733974427527
Current ratio: 10.641173545499752
Quick ratio: 10.357036300348085
Interest coverage ratio: -180.64548494983276
COGS to revenue (%): 45.8813422276127
R&D to revenue (%): 245.33050333535476
SG&A to revenue (%): 88.4778653729533
Free cash flow (dilution-adjusted): -84346987.95180723
Buyback yield (%): 0
Retained earnings: -243153012.04819277
Inventory turnover: 1.5889044452222614
Receivables turnover: 1.6734038054968288
Capitalized R&D asset: 58489156.62650603
ROCI (R&D-adjusted, %): -7.518501925728353
FCF margin (%): -353.79017586416006
Rule of 40 score: -353.79017586416006
Financial ratios for CWR.L — annual report dated 2023-12-31
Total revenue: 28258227.848101266
Gross profit: 17156962.025316454
Operating income: -75191139.24050632
Net income: -68364556.96202531
Capital expenditures: 9743037.974683544
Operating cash flow: -42910126.58227848
Depreciation & amortization: 11551898.734177215
Net tangible assets: 204532911.39240506
Owner earnings: -66555696.20253164
Return on net tangible assets (%): -32.54033580680897
Buffett classification: The Gruesome
Stock price: 0.023164556962025316
Shares outstanding: 213797576
Book value: 228651898.7341772
P/B ratio: 0.021659676368367152
Market cap (USD): 4952526.127594937
Debt to equity: 0.014371522683865252
Current ratio: 7.735551923934037
Quick ratio: 7.595651958599515
Interest coverage ratio: -136.2408256880734
COGS to revenue (%): 39.28507435943379
R&D to revenue (%): 242.04443648091737
SG&A to revenue (%): 101.17362479842322
Free cash flow (dilution-adjusted): -61630379.74683544
Buyback yield (%): 0
Retained earnings: -323744303.79746836
Inventory turnover: 3.1044247787610617
Receivables turnover: 6.523670368205728
Capitalized R&D asset: 107585203.29418942
ROCI (R&D-adjusted, %): -14.301099119038582
Rosenberg metric: 0.07274087424324674
FCF margin (%): -218.09711521232754
Revenue growth (%): 18.528042823549875
Rule of 40 score: -199.56907238877767
Financial ratios for CWR.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 167323750
Buffett classification: The Gruesome
Stock price: 0.021374999999999998
Shares outstanding: 213797576
Book value: 192291250
P/B ratio: 0.023765632533981652
Market cap (USD): 4569923.187
Debt to equity: 0.01445073553788849
Current ratio: 5.97524418238286
Quick ratio: 5.851195030832246
Buyback yield (%): 0
Retained earnings: -353873750
Capitalized R&D asset: 0
Rule of 40 score: 0